Status:
TERMINATED
Ultrasound-guided Venous Access for Pacemaker and Defibrillator Implants
Lead Sponsor:
Region Skane
Conditions:
Cardiac Arrhythmia
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study will include patients scheduled for transvenous pacemaker- or implantable defibrillator surgery, where venous access is necessary for lead implantation. A 1:1 randomization will be performed...
Detailed Description
Pacemaker- and defibrillator lead implants typically involve vascular access via the left cephalic, axillar or subclavian vein. Gaining access is usually straight forward for an experienced surgeon/im...
Eligibility Criteria
Inclusion
- Planned pacemaker or implantable defibrillator surgery with at least one new transvenously placed lead.
Exclusion
- Difficult vascular access known before surgery, where special access technique is planned or required.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 27 2025
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04867460
Start Date
April 1 2021
End Date
February 27 2025
Last Update
March 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skane University Hospital
Lund, Sweden